FDA Grants Fast Track Designation to 9MW2821 for the Treatment of Patients with Locally Advanced...

Sanyou Bio Collaborates on ADC Drug Development Entering Phase I Clinical Trials

FDA Grants Orphan Drug Designation to 7MW3711

SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline